On the 21st, the pharmaceutical sector theme showed strength, rising 3.05% compared to the previous day, while Bukwang Pharm, gaining attention as a related stock, surged 6.18% compared to the previous day. Bukwang Pharm is known as a manufacturer of pharmaceuticals and quasi-drugs (such as toothpaste).


[Graph] Major stock price changes in the pharmaceutical sector theme




According to provisional data compiled at 11:31, Bukwang Pharm is experiencing large net purchases by institutions, with institutions buying 100,000 shares.


[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)




According to the analysis by Thinkpool Robo Algorithm RASSI, Bukwang Pharm’s quant financial score is 17.99 points, ranking 59th in the pharmaceutical sector theme. This can be interpreted as Bukwang Pharm having relatively low investment attractiveness from a financial perspective. On the other hand, Daehan Pharm ranked first in quant financial score with higher growth, stability, and profitability scores compared to the average of other stocks.


[Table] Top stocks by financial score within the theme



※ The quant financial score is the result of the robo algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.







This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing